Previous Page  1173 / 1245 Next Page
Information
Show Menu
Previous Page 1173 / 1245 Next Page
Page Background

Warsaw 2017

Sample DVC’s (Head and Neck)

at St. Luke’s, Beaumont & St. James’s Hospitals

Evaluation Form for Head and Neck

Patient Name:

<Full Name>

Patient ID Number:

<Patient Id 1>

Consultant:

<Primary Care Physician - Name (Default)>

Date of Birth:

Date:

<Current Date>

Diagnosis:

<All Primary Diagnoses - With Staging Info (Default)>

Dose

PTV1

Fractions Dose

PTV2

Fractions Dose

PTV3

Fractions

Gy

Gy

Gy

Dose

95%

107%

70

66.5

74.9

63

59.9

67.4

60

57.0

64.2

56

53.2

59.9

50

47.5

53.5

46

43.7

49.22

EVALUATION OF PTV 3DCRT

EVALUATION OF PTV/GTV – IMRT/VMAT

Dose

Optimal

Acceptable Variation

Result

D2% D50% D98%

PTV1

D

min

D

max

95%

<107%

>90%

<110%

%

%

PTV2

D

min

D

max

95%

<107%

>90%

<110%

%

%

Dose

Optimal

Acceptable Variation

Result

D2% D50% D98%

gtvpri70

V

95%

>100%

N/A

%

N/A N/A N/A

gtvnrt70

V

95%

>100%

N/A

%

N/A N/A N/A

gtvnlt70

V

95%

>100%

N/A

%

N/A N/A N/A

ptv1

V

95%

D

max

>99%

<107%

>95%

<110%

%

%

evalptv2

(NA for SIB)

V

95%

D

max

>99%

<107%

>95%

<110%

%

%

Evalptv3

(NA for SIB)

V

95%

D

max

>99%

<107%

>95%

<110%

%

%

evalptv1

cc @ 107% <1.5cc

< 6.5cc

cc

evalext-ptv

cc @ 110%

-

<1 cc

22

cc

Evaluation of OAR’s based on 1.8-2.0Gy per fraction

OAR

Dose

Constraint

Optimal

Acceptable Variation

Result

Toxicity Endpoint

Spinal cord

D

max

< 45Gy²²

< 50Gy

13

(0.2%)

<60Gy

13

(6%risk)

<69Gy

13

(50%risk)

Gy

0.2% myelopathy

Spinal cord 4mm D

max

< 47Gy

50Gy<1cc

22

Gy

Brainstem

D

max

D

1-10cc

<54Gy

3+23

60Gy

23

(0.03cc)

<59Gy

3

(risk<5%)

Gy

Gy

Neuropathy

/necrosis

Brainstem 3mm D

max

<54Gy²²

<60Gy²² (<1%)

Gy

Chiasm

D

max

< 54Gy¹

-3

55-60Gy¹⁺² (Risk3-7%)

>60Gy¹⁺² (Risk7-20%)

Gy

Optic Neuropathy

Chiasm 3mm D

max

<54Gy²²

Gy

Pituitary

D

max

< 45Gy

< 50Gy

12

Gy

Panhypo-

pituitarism

Temporal Lobe D

0-5cc

<69Gy

21

pharyngeal

constrictors

D

mean

≤50Gy

20

< 60Gy

20

Gy

Symptomatic

dysphagia and

aspiration

mandible - ptv

D

max

<70Gy

17

or

prescribed

dose

<73Gy to 1.5cc

<75Gy to 1cc

22

Gy

Oral cavity - ptv D

median

< 46Gy

16

Gy

Left

Right

Parotid

18

D

mean

<25Gy

17-19

<26Gy

17-19

Gy

Gy

Long-term salivary

function<25%

V

30Gy

<50%

17-19

Gy

Gy

Cochlea

D

mean

<45Gy

10-11

Gy

Gy

Sensory-neural

hearing loss

Eye

D

max

< 50Gy

4

Gy

Gy

Retinopathy

Lens

D

max

< 6Gy

4-5

Gy

Gy

Cataract

Optic Nerve

D

max

< 54Gy¹

-3

55-60Gy¹⁺² (Risk3-7%)

>60Gy¹⁺² (Risk >7-20%)

Gy

Gy

Optic Neuropathy

Optic Nerve 3mm D

max

<54Gy²²

Gy

Gy